32 results
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
9 May 24
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
9:09am
P. Tufano, Medical Director, Head and Neck Endocrine Surgery for the Sarasota Memorial Health Care System in Sarasota, Florida. “The cell-specific
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
Director, Head and Endocrine Surgery for the Sarasota Memorial Health Care System in Sarasota, Florida. “I am extremely encouraged by the early study
8-K
EX-99.1
nznv1d63qspnpf8rx
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
D
2ft ehn83enij25hbc
9 Jul 21
$50M in equity, sold $50M, 1 investor
1:52pm